SCOTUS denies Purdue petitions over OxyContin

17-11-2016

SCOTUS denies Purdue petitions over OxyContin

Brandon Bourdages / Shutterstock.com

The US Supreme Court has denied certiorari for Purdue Pharma in a dispute over four of its patents covering OxyContin (oxycodone hydrochloride) against Teva, Mylan, Amneal and Epic Pharma.


SCOTUS, Purdue Pharma, OxyContin, Amneal, Teva, Mylan, Epic Pharma, patent

LSIPR